NEW YORK, NY / ACCESS Newswire / August 11, 2025 / If you suffered a loss on your Alto Neuroscience, Inc. (NYSE:ANRO) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/alto-neuroscience-inc-lawsuit-submission-form?prid=160937&wire=1&utm_campaign=29 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or […]

NEW YORK CITY, NY / ACCESS Newswire / August 11, 2025 / WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Alto Neuroscience, Inc. (NYSE:ANRO): (i) pursuant and/or traceable to Alto’s initial public offering conducted on or about February 2, 2024 (the "IPO"); and/or (ii) securities between February

(NASDAQ:SRPT), NEW YORK, Aug. 11, 2025 (GLOBE NEWSWIRE) — Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces that a class action lawsuit has been filed against Sarepta Therapeutics, Inc. (“Sarepta” or the “Company”) (NASDAQ:SRPT) in the United States District Court for the Southern District of New York on behalf of

SAREPTA (SRPT) LAWSUIT ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Sarepta Therapeutics, Inc. and Encourages Investors to Contact the Firm GlobeNewswire August 11, 2025 NEW YORK, Aug. 11, 2025 (GLOBE NEWSWIRE) — Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces

Steel Rebar Market worth $268.4 billion by 2030, at a CAGR of 4.0%, says MarketsandMarkets(TM) GlobeNewswire August 11, 2025 Delray Beach, FL, Aug. 11, 2025 (GLOBE NEWSWIRE) — The Steel Rebar Market was USD 212.9 billion in 2024, and it is projected to reach USD 268.4 billion in 2030, at a CAGR of 4.0%, registering

(CNSX:RVV.CN),(CNSX:RVV),(OTC US:RVVTF),(Other OTC:RVVTF),(Frankfurt:31R), TORONTO, Aug. 11, 2025 (GLOBE NEWSWIRE) — Revive Therapeutics Ltd. (“Revive” or the “Company“) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT: 31R), a specialty life sciences company dedicated to developing innovative therapeutics for critical medical needs, announces that it has closed the first tranche of its previously announced private placement offering (the “Offering“). The

Revive Therapeutics Announces Closing of First Tranche of Private Placement and Debt Settlement GlobeNewswire August 11, 2025 TORONTO, Aug. 11, 2025 (GLOBE NEWSWIRE) — Revive Therapeutics Ltd. (“Revive” or the “Company“) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT: 31R), a specialty life sciences company dedicated to developing innovative therapeutics for critical medical needs, announces that it has

(NYSE:HIMS), Bragar Eagel & Squire, P.C. Litigation Partners Brandon Walker and Marion Passmore Encourage Investors Who Suffered Losses In Hims To Contact Them To Discuss Their Options If you purchased or acquired securities in Hims between April 29, 2025 and June 23, 2025 and would like to discuss your legal rights, call Bragar Eagel &

HIMS LAWSUIT ALERT: Bragar Eagel & Squire, P.C. Reminds Investors of Hims That A Lawsuit Has Been Filed and Urges Investors to Contact The Firm GlobeNewswire August 11, 2025 Bragar Eagel & Squire, P.C. Litigation Partners Brandon Walker and Marion Passmore Encourage Investors Who Suffered Losses In Hims To Contact Them To Discuss Their Options

Granite Asia today announced the appointment of three new Managing Partners, further strengthening the firm's leadership across equity and private credit. These appointments reflect Granite Asia's continued commitment to deep sector expertise, global perspective, and long-term value creation for its investors and portfolio companies. Ming Eng Managing Partner, Private Credit (effective September 1, 2025) Ming